A lot more to digest from the report, but what I read below is quite compelling so clinical efficacy is almost proven in Japanese jurisdiction but for different use
Ann: Half-Year Financial Report & Appendix 4D - 31 December 2023, page-3
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
-0.015(3.19%) |
Mkt cap ! $250.3M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 49.0¢ | 45.5¢ | $1.515M | 3.232M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 161532 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 33998 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |